ZA8601211B - Analgesic composition - Google Patents

Analgesic composition

Info

Publication number
ZA8601211B
ZA8601211B ZA861211A ZA8601211A ZA8601211B ZA 8601211 B ZA8601211 B ZA 8601211B ZA 861211 A ZA861211 A ZA 861211A ZA 8601211 A ZA8601211 A ZA 8601211A ZA 8601211 B ZA8601211 B ZA 8601211B
Authority
ZA
South Africa
Prior art keywords
analgesic composition
analgesic
composition
Prior art date
Application number
ZA861211A
Inventor
Martin Dennis Hynes
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US70517685A priority Critical
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA8601211B publication Critical patent/ZA8601211B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
ZA861211A 1985-02-25 1986-02-18 Analgesic composition ZA8601211B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US70517685A true 1985-02-25 1985-02-25

Publications (1)

Publication Number Publication Date
ZA8601211B true ZA8601211B (en) 1987-10-28

Family

ID=24832355

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA861211A ZA8601211B (en) 1985-02-25 1986-02-18 Analgesic composition

Country Status (6)

Country Link
EP (1) EP0193355B1 (en)
JP (1) JPH0745405B2 (en)
AU (1) AU584681B2 (en)
CA (1) CA1267092A (en)
DE (1) DE3684626D1 (en)
ZA (1) ZA8601211B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058272T3 (en) * 1987-05-04 1994-11-01 Lilly Co Eli Fluoxetine useful for the treatment of diabetes.
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
ES2103682B1 (en) * 1995-09-20 1998-04-01 Lilly Sa Fluoxetine oral pharmaceutical composition, solid and with improved organoleptic characteristics.
DK2266564T3 (en) * 1997-12-22 2013-06-03 Euro Celtique Sa A pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
SI2092936T1 (en) 2000-02-08 2013-07-31 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
CA2446550C (en) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
WO2003007802A2 (en) 2001-07-18 2003-01-30 Euro-Celtique, S.A. Pharmaceutical combinations of oxycodone and naloxone
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
EP1414451B1 (en) 2001-08-06 2009-05-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
TWI334779B (en) 2002-04-05 2010-12-21 Euro Celtique Sa Pharmaceutical preparation containing oxycodone and naloxone
US20100189797A1 (en) * 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
AU2003229408A1 (en) * 2002-06-10 2003-12-22 Philippe Kriwin Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor
EP2422775A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
PL2484346T3 (en) 2006-06-19 2017-07-31 Alpharma Pharmaceuticals Llc Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
JP2016525138A (en) 2013-07-23 2016-08-22 ユーロ−セルティーク エス.エイ. The combination of oxycodone and naloxone for use in the treatment of pain in patients suffering from diseases increase the risk for diseases and / or Enterobacteriaceae migration results in pain and intestinal Disconnect bio cis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1373M (en) * Soc Ind Fab Antibiotiques Sifa therapeutic composition.
US4035511A (en) * 1976-05-06 1977-07-12 Massachusetts Institute Of Technology Process for promoting analgesia
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Also Published As

Publication number Publication date
EP0193355A2 (en) 1986-09-03
JPS61200911A (en) 1986-09-05
EP0193355B1 (en) 1992-04-01
CA1267092A1 (en)
EP0193355A3 (en) 1989-04-05
JPH0745405B2 (en) 1995-05-17
AU5400186A (en) 1986-08-28
DE3684626D1 (en) 1992-05-07
AU584681B2 (en) 1989-06-01
CA1267092A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
DE3572767D1 (en) Pharmaceutical composition
GB2153678B (en) Pharmaceutical composition
GB2186798B (en) Irrigation composition
KR960014788B1 (en) Shampoo composition
GB2152815B (en) Analgesic compositions
GB2167663B (en) Analgesic compositions
EG19470A (en) Shampo compositions
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
DE3664332D1 (en) Curable composition
GB8528633D0 (en) Compounds
GB8412357D0 (en) Pharmaceutical composition
GB8526078D0 (en) Pharmaceutical composition
GB8527052D0 (en) Compounds
IE58712B1 (en) Pharmaceutical compositions
IE862543L (en) Pharmaceutical compositions
IL78470A (en) Chemiluminescent composition
IE861842L (en) Pharmaceutical compositions
GB8626808D0 (en) Pharmaceutical compositions
IE862554L (en) Pharmaceutical compositions
GB8611062D0 (en) Topical compositions
JPS60146824A (en) Analgesic composition
JPS6075429A (en) Analgesic composition
GB8727836D0 (en) Pharmaceutical compositions
GB2179338B (en) Composition
EP0215670A3 (en) Anti-corrosion composition